Vasculitis Integrated Clinical Assessment Database: A Data Management System to Support Studies Into Systemic Vasculitis

Background:The systemic vasculitides are characterized by immune inflammation affecting blood vessels, which can lead to organ and tissue damage. Treatment has improved but optimum long-term management still remains unsatisfactory, requiring ongoing therapeutic studies. These often base their measures of efficacy on the outcome of clinical assessments which include the Birmingham Vasculitis Activity Score and the Vasculitis Damage Index. Objectives:Efficient management of assessment data is complex and often hampered by working with time-consuming paper-based systems. The Vasculitis Integrated Clinical Assessment Database (VICAD) was created to improve the process. Methods:VICAD was developed using Microsoft Access. Visual Basic for Applications and the Data Access Objects Application Programming Interface provide the functionality to assist with scoring, calculation of results, and storing of data. Results:VICAD is an efficient system for managing data. Evaluation of its use showed an improvement in the completeness of patient assessments from 77% (paper based: n = 44) to 98% (computer based: n = 30). During development clinicians (n = 4) rated it at 8/10 for its layout and visual presentation and 8/10 for easy to use (intuitiveness and navigability). Conclusions:The development of an integrated and standardized system of data collection (VICAD) helps to support clinical decision making processes and report findings in a more timely manner. It is available free for use and modification under the GNU General Public License. The open source nature of VICAD could help to inform the design of other databases where management of complex information into important multisystem diseases is needed.

[1]  David Steven Scott,et al.  Modification and validation of the Birmingham Vasculitis Activity Score (version 3) , 2008, Annals of the rheumatic diseases.

[2]  D. Machin,et al.  Computerized administration of health-related quality of life instruments compared to interviewer administration may reduce sample size requirements in clinical research: a pilot randomized controlled trial among rheumatology patients. , 2007, Clinical and experimental rheumatology.

[3]  P. Bacon,et al.  Development of comprehensive disease assessment in systemic vasculitis. , 2007, Annals of the rheumatic diseases.

[4]  Karen Jacobs,et al.  Usability of a barcode scanning system as a means of data entry on a PDA for self-report health outcome questionnaires: a pilot study in individuals over 60 years of age , 2006, BMC Medical Informatics Decis. Mak..

[5]  M. C. Greenwood,et al.  Touch screen computers in the rheumatology clinic , 2006 .

[6]  B. Espehaug,et al.  The impact of body mass index on later total hip arthroplasty for primary osteoarthritis: a cohort study in 1.2 million persons. , 2006, Arthritis and rheumatism.

[7]  Lars Klareskog,et al.  as p38 MAP kinases and NF (cid:6) B in the modulation of the anticoagulant effects of statins. OP44. PHASED DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION IN SYSTEMIC VASCULITIS , 2006 .

[8]  D V Doyle,et al.  Touch-screen computer systems in the rheumatology clinic offer a reliable and user-friendly means of collecting quality-of-life and outcome data from patients with rheumatoid arthritis. , 2006, Rheumatology.

[9]  D. Scott,et al.  Primary systemic vasculitis: clinical features and mortality. , 2005, QJM : monthly journal of the Association of Physicians.

[10]  N. Bellamy,et al.  Validation and patient acceptance of a computer touch screen version of the WOMAC 3.1 osteoarthritis index , 2004, Annals of the rheumatic diseases.

[11]  T. Sokka Rheumatoid arthritis databases. , 2004, Rheumatic diseases clinics of North America.

[12]  Leslie Lenert,et al.  A web-compatible instrument for measuring self-reported disease activity in arthritis. , 2004, The Journal of rheumatology.

[13]  V. Tesar,et al.  A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. , 2003, The New England journal of medicine.

[14]  P. Bacon,et al.  Validation of BVAS and VDI as tools to assess Systemic Vasculitis in India , 2003 .

[15]  M. Dougados,et al.  Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel , 2003, Annals of the rheumatic diseases.

[16]  M. A. Albornoz,et al.  An Overview of the Use of Computers in Clinical Rheumatology: Models of Care for the Next Millennium , 2003, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[17]  George D. Kitas,et al.  Computerized information-gathering in specialist rheumatology clinics: an initial evaluation of an electronic version of the Short Form 36. , 2002, Rheumatology.

[18]  P. Bacon,et al.  Activity, damage and outcome in systemic vasculitis. , 2001, Best practice & research. Clinical rheumatology.

[19]  C. Gordon,et al.  Damage occurs early in systemic vasculitis and is an index of outcome. , 1997, QJM : monthly journal of the Association of Physicians.

[20]  C. Gordon,et al.  Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. , 1997, Arthritis and rheumatism.

[21]  R. Moots,et al.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. , 1994, QJM : monthly journal of the Association of Physicians.

[22]  D. Symmons,et al.  Development and Assessment of a Computerized Index of Clinical Disease Activity in Systemic Lupus Erythematosus , 1988 .